Problem solving steps

Similar documents
Exothermic vs endothermic

Biological Thermodynamics

Chemistry 123: Physical and Organic Chemistry Topic 2: Thermochemistry S H 2 = S H 2 R ln P H2 P NH

Lecture 2: Biological Thermodynamics [PDF] Key Concepts

Microcalorimetry for the Life Sciences

Concept review: Binding equilibria

Entropy. ΔS = q rev T. CLASSICAL THERMODYNAMICS study of macroscopic/thermodynamic properties of systems: U, T, V, P,

Exp.3 Determination of the Thermodynamic functions for the Borax Solution

Thermodynamics of Borax Dissolution

a) Write the reaction that occurs (pay attention to and label ends correctly) 5 AGCTG CAGCT > 5 AGCTG 3 3 TCGAC 5

Problem Set 5 Question 1

I: Life and Energy. Lecture 2: Solutions and chemical potential; Osmotic pressure (B Lentz).

General Chemistry revisited

Presentation Microcalorimetry for Life Science Research

ISoTherMal TITraTIon Calorimetry

LABORATORY OF ELEMENTARY BIOPHYSICS. Isothermal Titration Calorimetry as a tool for determining thermodynamic parameters of chemical reactions

A) at equilibrium B) endergonic C) endothermic D) exergonic E) exothermic.

concentrations (molarity) rate constant, (k), depends on size, speed, kind of molecule, temperature, etc.

schematic diagram; EGF binding, dimerization, phosphorylation, Grb2 binding, etc.

MicroCal itc 200. System MicroCal Auto-iTC 200. System. GE Healthcare Life Sciences. System design and description. provide:

ITC Expert User s Manual

Problem Set # 1

THE THERMODYNAMICS OF POTASSIUM NITRATE DISSOLVING IN WATER 1

Q1: Sumatriptan (Tosymra) type

Binding Theory Equations for Affinity and Kinetics Analysis

Ionization of acids and bases

S2004 Methods for characterization of biomolecular interactions - classical versus modern

THE THERMODYNAMICS OF POTASSIUM NITRATE DISSOLVING IN WATER V010516

Waves. λ = c / f ω = 2π f = 2π / T. E = hf = ω E mole = N A. E X ray. ~ ~ J / mol! Wilhelm Röntgen

Statistical mechanics of biological processes

CHEM 341 PHYSICAL CHEMISTRY FINAL EXAM. Name

Biology Chemistry & Physics of Biomolecules. Examination #1. Proteins Module. September 29, Answer Key

CHEM 341 PHYSICAL CHEMISTRY FINAL EXAM. Name

PHYSIO-CHEMICAL PROPERTIES OF THE DRUG. It is the interaction of the drug with its environment

Table 1. Kinetic data obtained from SPR analysis of domain 11 mutants interacting with IGF-II. Kinetic parameters K D 1.

Full file at

Worksheet 5.2. Chapter 5: Energetics fast facts

Physical Biochemistry. Kwan Hee Lee, Ph.D. Handong Global University

Chem/Biochem 471 Exam 2 11/14/07 Page 1 of 7 Name:

Isothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017

MCB100A/Chem130 MidTerm Exam 2 April 4, 2013

Dr. White Chem 1B Saddleback College 1. Experiment 15 Thermodynamics of the Solution Process

Table of Contents. * * * * * Volume 1

A. One-Substrate Reactions (1) Kinetic concepts

CHEM Exam 3 - March 31, 2017

Unit 12. Thermochemistry

Multivalent interactions in human biology

AP CHEMISTRY 2007 SCORING GUIDELINES (Form B)

Atomic Properties of Carbon

Supplementary Information

Isothermal titration calorimetry (ITC)

Substrate-dependent switching of the allosteric binding mechanism of a dimeric enzyme

Exam 3 Solutions. ClO g. At 200 K and a total pressure of 1.0 bar, the partial pressure ratio for the chlorine-containing compounds is p ClO2

Chemistry 425 September 29, 2010 Exam 1 Solutions

Cholera Toxin Invasion

10/16/17 ACIDS AND BASES, DEFINED WATER IS AMPHOTERIC OUTLINE. 9.1 Properties of Acids and Bases. 9.2 ph. 9.3 Buffers

S and G Entropy and Gibbs Free Energy

Chapter 19 Chemical Thermodynamics

LS1a Midterm Exam 1 Review Session Problems

Supplementary Figures

11. What are the four most abundant elements in a human body? A) C, N, O, H, P B) C, N, O, P C) C, S, O, H D) C, Na, O, H E) C, H, O, Fe

Reaction rate. reaction rate describes change in concentration of reactants and products with time -> r = dc j

rate of reaction forward conc. reverse time P time Chemical Equilibrium Introduction Dynamic Equilibrium Dynamic Equilibrium + RT ln f p

Ch. 19 Entropy and Free Energy: Spontaneous Change

CHEMISTRY OF THE HUMAN BODY

CHAPTER 2. Structure and Reactivity: Acids and Bases, Polar and Nonpolar Molecules

Lecture 6. NONELECTROLYTE SOLUTONS

Chapter 27. Energy and Disorder

Class XI Chapter 6 Thermodynamics Chemistry

Supporting Information

Supplementary Materials: Probing the Ion Binding Site in a DNA Holliday Junction Using Förster Resonance Energy Transfer (FRET)

5.111 Lecture Summary #30 Monday, November 24, 2014

More Tutorial at

A primer on pharmacology pharmacodynamics

Comparison of log P/D with bio-mimetic properties

Lecture 27. Transition States and Enzyme Catalysis

LECTURE 6 NON ELECTROLYTE SOLUTION

Activation Free Energies in Partial Steps of the. Sarcoplasmic Reticulum Ca-ATPase Cycle during. the Transient States of the Reaction

Initial amounts: mol Amounts at equilibrium: mol (5) Initial amounts: x mol Amounts at equilibrium: x mol

Free Energy. because H is negative doesn't mean that G will be negative and just because S is positive doesn't mean that G will be negative.

2/25/2015. Chapter 4. Introduction to Organic Compounds. Outline. Lecture Presentation. 4.1 Alkanes: The Simplest Organic Compounds

The Second Law of Thermodynamics (Chapter 4)

CHEM N-2 November 2014

7/19/2011. Models of Solution. State of Equilibrium. State of Equilibrium Chemical Reaction

MEDCHEM 562 Kent Kunze Lecture 2. Physicochemical Properties of Drugs and Drug Disposition. Stereochemistry (Double the trouble. or double the fun?

Thermodynamics of cationic and anionic surfactant interaction

Lecture 2: Receptor-ligand binding and cooperativity

CHEMISTRY OF THE HUMAN BODY

Please read and sign the Honor Code statement below:

Chemical Thermodynamics. Chapter 18

Recommended Reading: 23, 29 (3rd edition); 22, 29 (4th edition) Ch 102 Problem Set 7 Due: Thursday, June 1 Before Class. Problem 1 (1 points) Part A

Chapter 17.3 Entropy and Spontaneity Objectives Define entropy and examine its statistical nature Predict the sign of entropy changes for phase

CHEMISTRY - CLUTCH CH CHEMICAL THERMODYNAMICS.

The energy of oxidation of 11 g glucose = kj = kg/m 2 s 2

1 What is energy?

7.012 Problem Set 1. i) What are two main differences between prokaryotic cells and eukaryotic cells?

Chemistry 2000 Fall 2017 Final Examination

NAME: Chapter 14Chemical Kinetics (Reaction Rate Law Concepts)

ASSIGNMENT SHEET #11 APQ ANSWERS

Gibbs Free Energy. Evaluating spontaneity

Transcription:

Problem solving steps Determine the reaction Write the (balanced) equation ΔG K v Write the equilibrium constant v Find the equilibrium constant using v If necessary, solve for components K K = [ p ] ν i i i products ν [ r ] j j reactants ΔG = exp RT j 0 K ΔG v Find the equilibrium constant using v Find ΔG using 0 ΔG = RT ln K K = [ p ] ν i i i products ν [ r ] j j reactants j [r] [p] v Use equilibrium constant definition

Reactions: phase partition, LogP Two immiscible phases, e.g.: v cellular membrane (lipid) and extracellular fluid (aqueous) v cellular membrane (lipid) and cytoplasm (aqueous) v octanol (non-polar) and water (polar) experimental model system Reaction of spontaneous transfer of the compound from non-polar to polar phase: v cpd dissolved in non-polar phase same cpd dissolved in polar phase K = Coct/CH2O (ratio of two concentrations) Popular compound characteristic: v logp = log10 (Coct/CH2O) K = 10logP May need to use molar amt = conc x volume

Phase Partition Equilibrium I Problem: 4.02 mmol of a compound with logp = 2.3 is added to a container with 0.5L octanol and 0.5L water. Find the concentrations of the compound in water and octanol after the system equilibrates. Solution: v Reaction: Compound in H 2 O Compound in Octanol v logp = 2.3 K = C oct / C H2O = 10 2.3 200, so C oct 200 C H2O Molar amount Concentration Volume Water x [mol] x / 0.5 L = 2x [M] 0.5 L Octanol 200x [mol] 200 C H2O = 400x [M] 0.5 L v 200x + x = 4.02 mmol 201x = 4.02 10 3 mol x = 20 µmol v 20 µmol in water, 4 mmol in octanol v Concentrations: 20 µmol / 0.5 L = 40 µm in water, 4 mmol / 0.5 L = 8 mm in octanol (sanity check, please?) Answer: 40 µm and 8 mm

Phase Partition Equilibrium II Problem: 12.3 µmol of a compound with logp = 2.3 is added to a container with 0.5L octanol and 2.5L water. Find the concentrations of the compound in water and octanol after the system equilibrates. Solution: v Reaction: Compound in H 2 O Compound in Octanol v logp = 2.3 K = C oct / C H2O = 10 2.3 200 and C oct 200 C H2O Molar amount Concentration Volume Water x mol x / 2.5 L = 0.4x M 2.5 L Octanol 200*(0.5/2.5)= 40x mol 200 C H2O = 80x M 0.5 L v 40x + x = 12.3 µmol 41x = 12.3 10 6 mol x = 0.3 µmol v 0.3 µmol in water, 12 µmol in octanol v Concentrations: 0.3 µmol / 2.5 L = 0.12 µm in water, 12 µmol / 0.5 L = 24 µm in octanol (sanity check, please?) Answer: 0.12 µm and 24 µm

Phase Partition, K to ΔG Problem: 4.6 mmol of a compound was added to a container with 1L octanol and 3L water. After the system equilibrated, the aqueous concentration of the compound was found to be 0.2 mm. Find the compound logp and molar ΔG of its transition from octanol to water. Solution: Molar amount Concentration Volume Water 0.2 mm 3L = 0.6 mmol 0.2 mm 3L Octanol 4.6 0.6 = 4 mmol 4 mmol / 1L = 4mM 1L v logp = log C oct / C H2O = log (4mM / 0.2 mm) = log 20 ~ 1.3 v ΔG = RT ln C H20 /C oct v ΔG= 0.6 ln 1/20 = 0.6 ln 20 = 0.6 3 = 1.8 kcal/mol (sanity check?) Answer: logp = 1.3, ΔG (octanol water) = 1.8 kcal/mol Useful hint: ln 20 ~ 3.

Favorite reactions: conformational transition Compound has two distinct stereo-isomers, e.g.: v (if there is a chiral center) (S) and (R) v (if there is a double bond) cis- and trans- v state A and state B Reaction of spontaneous transition: v A B K = C B /C A (ratio of two concentrations) Enantiomers: Cis- and Trans- isomers: trans- cis- (S)-thalidomide Teratogenic (R)-thalidomide Safe, effective against morning sickness

Problem: Isomerisation, ΔG to K The Gibbs free energies of formation of two stereoisomers, X and Y, of a compound at T = 300K are G f (X)=93.2 kcal/mol and G f (Y) = 96.2 kcal/mol. Estimate the molar fraction of [Y] in the (equilibrium) racemic mixture at this temperature. Solution: v Reaction Y X v ΔG = G f (X) G f (Y) = 3 kcal/mol v Find the equilibrium constant, K = [X]/[Y] v K = exp ( ΔG / RT) = exp (3 / 0.6) = exp 5 ~ 149 v [X]/[Y] ~ 149/1 (sanity check, please?) v Molar fraction of Y is [Y]/([Y]+[X]) ~ 1 / 150 Answer: ~ 1/150

Favorite reactions: 1:1 protein-ligand binding Compound (ligand) binds to its target in 1:1 stoichiometry Reaction: P + L PL K a = [PL] / [P][L] (association constant, binding constant, affinity constant, binding affinity ) K d = [P][L] / [PL] (dissociation constant) = 1/K a ΔG bind = RT ln K a AND ΔG bind = RT ln K d

Protein-ligand binding, K to ΔG In the solution at equilibrium, the concentrations of unbound drug and protein are 13.5 nm and 0.5 nm, respectively, while the concentration of protein/drug complex is 4.5 nm. Find ΔG binding. Solution: v Reaction: P + L PL v Kd = [P][L] / [PL] = 13.5 10 9 0.5 10 9 / (4.5 10 9 ) = 1.5 nm v Ka = 1 / (1.5 10 9 ) ~ 0.67 10 9 M 1 v ΔG = RT ln Ka = RT ln Kd v ΔG = 0.6 ( 9 ln 10 + ln 1.5) 12.19 kcal/mol Answer: ΔG 12.19 kcal/mol

K 2 / K 1 = 10 Shortcut: K to ΔG ΔG 2 ΔG 1 = RT ln K 2 + RT ln K 1 = RT ln (K 2 / K 1 ) ΔG 2 ΔG 1 = 0.6 ln 10 0.6 2.3 1.4 kcal/mol K increases by a factor of 10 when ΔG decreases by 1.4 kcal/mol For example: correspondence between ΔG and Kd for protein/ligand binding: ΔG bind Kd -4.14 1 mm -8.23 1 µm -12.43 1 nm -16.58 1 pm -20.72 1 fm

Problem: Protein/drug binding, using K to ΔG shortcut A drug candidate was chemically optimized to reduce the therapeutic concentration 1000 times. Estimate the binding energy improvement required to reach that goal. Solution: v 10-fold Kd improvement 1.4 kcal/mol decrease in ΔG v 100-fold Kd improvement 2.8 kcal/mol decrease in ΔG v 1000-fold Kd improvement 4.2 kcal/mol decrease in ΔG Answer: The binding energy needs to be decreased by 4.2 kcal/mol.

Protein-ligand binding equilibrium Problem: In the solution at equilibrium, the concentrations of unbound drug and protein are 13.5 nm and 0.5 nm, respectively. Given the Kd of 1.5 nm, estimate the fraction of total protein which is bound (the binding reaction has 1:1 stoichiometry). Solution: v Reaction: P + L PL, v Kd = [P][L] / [PL] = 1.5 10 9 M v [PL] = [P][L] / Kd = 0.5 10 9 13.5 10 9 / (1.5 10 9 ) = 4.5 10 9 M v Unbound protein: 0.5 nm, bound protein 4.5 nm, total 5 nm v Fraction bound = 4.5 / 5 = 90% Answer: 90% of the protein is bound.

Protein-Ligand Binding Equilibration Simplest case, 1:1 binding stoichiometry P + L PL Eq. constant of the forward reaction: Ka = [PL]/[P][L] Eq. constant of the reverse reaction: Kd = [P][L]/[PL] dissociation constant, widely used to describe proteinligand binding v At equilibrium, Kd = [P][L] / [PL] x Kd = (P 0 x)(l 0 x) v x Kd = x 2 (P 0 +L 0 )x + P 0 L 0 v x 2 (P 0 +L 0 +Kd) x + P 0 L 0 = 0 - quadratic v a = 1; b = (P 0 +L 0 +Kd); c = P 0 L 0 v Solve ax 2 + bx + c = 0 Protein Ligand Complex Start (no equilibrium) [P] = P 0 [L] = L 0 0 Equilibration [P] = P 0 x [L] = L 0 x [PL] = x

Example 0.30 µm of protein is mixed with 0.36 µm of drug. The dissociation constant is K d = 0.01 µm. Evaluate the bound protein concentration after the system equilibrates. Solution: Protein Ligand Complex Start (no equilibrium) [P] = P 0 [L] = L 0 0 Equilibration [P] = P 0 x [L] = L 0 x [PL] = x v x 2 (P 0 +L 0 +K d ) x + P 0 L 0 = 0 quadratic v Assuming that x, P 0, L 0, and K d are all measured in the same units (e.g. µm), we can cancel out the prefix factor (e.g. 10 6 )

Example cntd. v a = 1 v b = (0.30+0.36+0.01) = 0.67 v c = 0.30 0.36 = 0.108 v Solve ax 2 + bx + c = 0 v x = ( b ± Sqrt(b 2 4ac)) / 2a = 0.27 µm or 0.40 µm v x cannot exceed P 0 or L 0, so x = 0.27 µm (use the solution with ) Protein Ligand Complex Start (no equilibrium) [P] = 0.3 µm [L] = 0.36 µm 0 Equilibration [P] x = 0.03µM [L] x = 0.09µM x = 0.27µM v And, BTW, (0.03µM 0.09µM) / 0.27µM = 0.01 µm = Kd Answer: 0.27µM

Equilibrium [PL] as a function of total ligand Given a test tube with the initial protein concentration P 0, how much complex is formed upon addition of L 0 (concentration) of ligand with a given Kd? x = L bound = P bound = P 0 + L 0 + K d P 0 + L 0 + K d ( ) 2 4P 0 L 0 2

Two types of titration curves Plot [PL] vs total ligand Straight line, fast saturation strong binding Differentiate Slope 0 strong binding [PL] (µm) Δ[PL] Slope << 0 weak binding Curved line, slow saturation weak binding P 0 = 10 µm, K d = 10 µm P 0 = 10 µm, K d = 1 µm P 0 = 10 µm, K d = 0.1 µm Total Ligand (µm) Total Ligand (µm)

If a drug could be profiled against all proteins in the body Primary target # of proteins in the body Secondary target(s), close homologs of primary target Plasma proteins (e.g. albumin) 11 10 9 8 7 6 5 4 3 2 ΔG bind (kcal/mol) (simulated histogram)

Total protein vs Kd: important cases P tot << K d [P] << K d [P] / K d << 1 [PL] << [L] Ligand is not depleted by binding to the protein True for most biological targets in vivo P tot > K d [P] ~ K d [P] / K d ~ 1 [PL] ~ [L] Ligand is depleted by binding to the protein True for albumin, antitrypsin and other abundant plasma proteins) Only unbound fraction exhibits pharmacological action.

If ligand is not depleted P tot << K d and [PL] << [L] [L tot ] [L] Target bound/unbound ratio (from definition of K d ): [PL] / [P] = [L] / K d ~ [L tot ] / K d When [L tot ] K d, [PL] = [P], i.e. K d is the ligand concentration at which 50% target is bound. Similarly, [L tot ] Kd [PL]/[P] for any bound/unbound ratio.

Kd ligand concentration at which 50% target is bound? P 0 = 1 nm Rule applicable P 0 = 10 µm Rule not applicable Kd = 10 µm Kd = 1 µm Kd = 10 µm Kd = 1 µm [PL] (µm) 50% protein bound [PL] (µm) 50% protein bound Works only when P 0 << Kd!!! 1 µm 10 µm Total Ligand (µm) 1 µm 10 µm Total Ligand (µm)

Example: using total Lig Kd [PL]/[P] The concentration of the target protein in the patient s body is 5 pm. Given a drug with Kd of 10 nm, what concentration of the drug is needed for 80% of the protein to be bound? Solution: v [P] << Kd v Desired [PL]/[P] ratio is 80/20 = 4/1 v Total ligand = [PL]/[P] Kd 40nM Answer: 40 nm Note: we need 90 nm drug for 90% bound protein, and 190 nm for 95% bound protein.

If ligand is depleted P tot > K d ; [PL] ~ [L] If protein is in excess, i.e. [PL] << [P] and [P tot ] [P] Ligand bound / unbound ratio (from definition of K d ): [PL] / [L] = [P] / K d ~ [P tot ] / K d [P tot ] / K d defines bound/unbound ratio for the ligand Fraction bound ligand = [P tot ] / ([P tot ] + K d )

High affinity drug-albumin binding Problem: Kd (Albumin, warfarin) is ~5 µm, calculate albumin binding in %, assuming albumin in physiological range. Solution: v [P tot ] / ([P tot ] + K d ) v with albumin concentration at 450 µm: 450 / 455 ~ 98.9% v with albumin concentration at 750 µm: 750 / 755 ~ 99.3% Note: unbound warfarin varies between 0.7% and 1.1%, i.e. 57% increase for a skinny fasting person For drugs with high plasma protein binding, small changes in plasma protein can dramatically affect free drug concentration.

Low affinity drug-albumin binding Example: Kd (Albumin, drug B) is ~5 mm, calculate albumin binding in %, assuming albumin in physiological range. Solution: v [P tot ] / ([P tot ] + K d ) v with albumin concentration at 450 µm: 450 / 5450 ~ 8.3% v with albumin concentration at 750 µm: 750 / 5750 ~ 13% Unbound drug B varies between 87% and 91.7%, i.e. only 5.5% increase for a skinny fasting person Variations of plasma concentrations of unbound drug B are not so dramatic.

Direct experimental determination of Kd Simultaneous monitoring of [P], [L], and [PL] is unfeasible Use several test tubes with the same P 0, add different total ligand concentrations OR: use a single test tube, add ligand in small injections Monitor one of the following: v [PL] v [P] (unbound protein concentration) v [L] (unbound ligand concentration) Plot the monitored value against total ligand Find Kd by fitting the curve into the equation (software available) ( ) P0 + L0 + Kd P0 + L0 + Kd 4P0 L0 x = 2 A precise method: Isothermal Titration Calorimetry, ITC 2

Isothermal Titration Calorimetry Drug is injected to the sample cell in equal doses The amount of heat on each injection is proportional to x = Δ[PL] The shape of the curve defines Kd ΔG The values on the curve define ΔH ΔS can be calculated from ΔG = ΔH TΔS ΔG ΔH TΔS